A lipid clinic is a specialist medical practice devoted entirely to diagnosing and treating disorders of cholesterol, triglycerides, and other blood fats. You would typically go when your lipid problems are too complex or stubborn for a general practitioner to manage alone, whether that means a suspected genetic condition, cholesterol that stays dangerously high despite medication, or side effects that have derailed your treatment. These clinics do more than re-run your cholesterol panel: they dig into advanced biomarkers, arrange genetic testing, and coordinate care across dietitians, pharmacists, and genetic counselors who all specialize in lipid disorders.
How a Lipid Clinic Differs From Your Regular Doctor’s Office
Your primary care doctor can handle straightforward high cholesterol in most cases. A lipid clinic picks up where that care runs out. The specialists working in these clinics, usually cardiologists, endocrinologists, or internists with advanced training in lipidology, spend their days on patients whose lipid profiles are unusually difficult to interpret or treat. One study of a specialist lipid clinic found that 66% of patients referred for primary prevention did not actually meet the treatment threshold used by their referring doctors, meaning the clinic’s first job was simply getting the diagnosis right. That same clinic identified 39 patients with previously undiagnosed diabetes or impaired glucose tolerance and 12 with undiagnosed hypothyroidism, both of which can drive cholesterol levels up and both of which are treatable once caught.1PubMed. The value of a specialist lipid clinic
Getting the underlying cause right matters because treating high cholesterol caused by an underactive thyroid, for example, looks completely different from treating an inherited condition. A lipid clinic’s diagnostic workup is built to tell those apart.
When You Should Ask About a Referral
There is no single cholesterol number that triggers a lipid clinic visit, but certain patterns strongly suggest you need one. The clearest situations include:
- Very high LDL cholesterol: If your LDL is persistently at or above 190 mg/dL, especially with a family history of high cholesterol or early heart disease, an inherited condition is likely and warrants specialist evaluation.
- Cholesterol that won’t budge: You have been on statins or other medications at appropriate doses, and your numbers remain well above goal.
- Statin intolerance: You have tried one or more statins and developed muscle pain or other side effects that forced you to stop. A lipid clinic can systematically work through alternative statins, doses, and dosing schedules, and if needed, move to non-statin therapies with proven outcomes data.2Journal of Clinical Lipidology. Update on statin intolerance: A final consensus statement from the National Lipid Association Expert Panel on Statin Intolerance
- Very high triglycerides: Levels above 500 mg/dL, and especially above 880 mg/dL, raise the risk of acute pancreatitis and often signal a genetic triglyceride disorder that general practitioners rarely encounter.
- A family history of early heart attacks or strokes: If close relatives had cardiovascular events before age 55 (men) or 65 (women), your lipid profile deserves a deeper look.
- Unusual physical signs: Tendon thickening, yellowish deposits around the eyes or on the skin (xanthomas), or a whitish ring around the cornea at a young age all point toward inherited lipid disorders.
You do not need to wait for a referral from your doctor in every health system, but in practice, most lipid clinics see patients on referral. If any of the patterns above sound familiar, it is worth raising the question at your next visit.
The Team You Will Meet
A well-staffed lipid clinic is not just one doctor. The National Lipid Association describes these clinics as multidisciplinary teams, and each member fills a distinct role.3Journal of Clinical Lipidology. Multidisciplinary teams in clinical lipidology and cardiometabolic care: An Expert Clinical Review from the National Lipid Association
Registered dietitian nutritionists provide what is formally called medical nutrition therapy: a personalized eating plan tailored to your specific lipid disorder and any other conditions you carry, such as diabetes or high blood pressure. For some genetic conditions, especially those involving extreme triglyceride levels, dietary management is the foundation of treatment. The American College of Cardiology, American Heart Association, and National Lipid Association all recommend referral to a dietitian for dyslipidemia management.3Journal of Clinical Lipidology. Multidisciplinary teams in clinical lipidology and cardiometabolic care: An Expert Clinical Review from the National Lipid Association
Genetic counselors are another piece of the team that most people do not expect. Their specialized training in medical genetics helps them select and interpret the right genetic tests, counsel patients and families on what inherited conditions mean, and provide emotional support around a diagnosis that affects your relatives too.4PubMed. The genetic counselor’s role in management of patients with dyslipidemia Clinical pharmacists round out the picture, managing medication regimens, monitoring for drug interactions, and often running the follow-up visits that track your progress.
Advanced Testing Beyond the Standard Lipid Panel
The cholesterol panel you get at your annual physical measures total cholesterol, LDL, HDL, and triglycerides. That is a useful starting point, but it can be insufficient and sometimes misleading.5PubMed Central. Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science A lipid clinic goes further, ordering tests that measure the particles carrying cholesterol rather than just the cholesterol riding inside them. Advanced lipid testing can include lipoprotein particle number and size, apolipoprotein B, apolipoprotein A-I, and lipoprotein(a).6PubMed Central. The role of advanced lipid testing in the prediction of cardiovascular disease
Two of these deserve special attention because they increasingly shape treatment decisions.
Apolipoprotein B
Apolipoprotein B, or apoB, is the protein found on every particle that can lodge in your artery walls and drive plaque buildup. Measuring apoB gives you a direct count of those dangerous particles. Research has shown that apoB outperforms standard LDL cholesterol in predicting cardiovascular risk, especially in people taking statins whose LDL looks fine but whose particle count remains high.7PubMed Central. Apolipoprotein B in the Risk Assessment, Diagnosis, and Treatment of Cardiometabolic Diseases This mismatch between your LDL number and your actual risk is exactly the kind of puzzle a lipid clinic is built to solve.
Lipoprotein(a)
Lipoprotein(a), written Lp(a), is a particle your liver makes in amounts that are almost entirely determined by your genes. Roughly 70% to over 90% of the variation in Lp(a) levels between people is genetic, and high levels are an independent, causal risk factor for heart disease through mechanisms that promote plaque growth, inflammation, and blood clotting.8PubMed Central. Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association The unsettling part is that Lp(a) can raise your cardiovascular risk even when your LDL cholesterol is within normal range.9PubMed Central. Lipoprotein(a) as a Risk Factor for Cardiovascular Diseases: Pathophysiology and Treatment Perspectives
In a large pooled U.S. study, people with Lp(a) levels at or above the 90th percentile had roughly a 46% higher risk of cardiovascular events compared with those below the 50th percentile, and the association was even stronger in people with diabetes, where the risk nearly doubled.10PubMed. Lipoprotein(a) and Long-Term Cardiovascular Risk in a Multi-Ethnic Pooled Prospective Cohort Most people have never had their Lp(a) measured. Because the level is genetically fixed, you only need to check it once in your life, and a lipid clinic will order it if your regular doctor has not.
Familial Hypercholesterolemia
Familial hypercholesterolemia, or FH, is the single most common reason people end up at a lipid clinic. It is an inherited condition that causes very high LDL cholesterol from birth and dramatically accelerates artery disease if left untreated. Diagnosis relies on a combination of clinical features, family history, elevated LDL levels, and increasingly, genetic testing.11PubMed Central. Familial hypercholesterolemia: A review
Lipid clinics use formal scoring systems to assess how likely FH is. The best known is the Dutch Lipid Clinic Network criteria, which assigns points for personal and family history, physical signs, and LDL levels to classify patients into probability categories. A comparison study found that in a Japanese population, a simpler three-criteria system outperformed the Dutch system in correctly identifying people who carried an FH-causing mutation while simultaneously ruling out those who did not.12Circulation Journal. Clinical Diagnostic Criteria of Familial Hypercholesterolemia ― A Comparison of the Japan Atherosclerosis Society and Dutch Lipid Clinic Network Criteria ― The takeaway for patients is that a lipid clinic has formal, validated tools for making the diagnosis, not just a gut feeling about a high number.
When genetic testing confirms FH, the clinic can trigger cascade screening, where your close relatives are offered testing too. FH runs in families in a clear pattern: each first-degree relative of someone with the condition has a 50% chance of inheriting it. Catching it early in a sibling or child means treatment can start before decades of damage accumulate.
Rare Lipid Disorders That Need Specialist Expertise
Beyond FH, a handful of rarer conditions land squarely in lipid clinic territory because general practitioners almost never see them.
Familial chylomicronemia syndrome (FCS) is a genetic disorder of extreme triglyceride elevation, typically above 880 mg/dL, that carries a high risk of recurrent acute pancreatitis. Diagnosis is frequently delayed because the condition is rare and the triglyceride levels resist conventional medications like statins, fibrates, and fish oil.13PubMed Central. Clinical considerations for the treatment of patients with familial chylomicronemia syndrome using a hepatic-targeted APOC3 antisense oligonucleotide Patients must follow a very strict low-fat diet, often limited to 15 to 20 grams of fat per day, and managing that diet over a lifetime is extremely challenging without help from a specialized team. The treatment landscape has recently changed: olezarsen, a drug that targets a protein called apolipoprotein C-III, became the first FDA-approved therapy specifically for FCS, offering a real treatment option beyond diet alone.13PubMed Central. Clinical considerations for the treatment of patients with familial chylomicronemia syndrome using a hepatic-targeted APOC3 antisense oligonucleotide Additional drugs using similar mechanisms are in late-stage development.14PubMed Central. Novel Therapeutics for Familial Chylomicronemia Syndrome
Dysbetalipoproteinemia is another condition a lipid clinic is equipped to diagnose. It causes a distinctive pattern of elevated cholesterol and triglycerides together, but the routine lipid panel cannot distinguish it from other forms of mixed high lipids. The definitive biochemical test requires a specialized laboratory technique called beta quantification, which separates lipoprotein fractions using ultracentrifugation.15PubMed. The clinical and laboratory investigation of dysbetalipoproteinemia This is not a test your primary care office will order, and interpreting the results requires experience with the condition.
A lipid clinic also works through a structured diagnostic algorithm when high cholesterol could stem from several possible genetic causes. The process starts by ruling out secondary causes like thyroid disease, then evaluates family history and LDL levels, and moves through candidate gene testing for conditions including FH, sitosterolemia, and others.16Journal of Clinical Lipidology. A mechanism-based operational definition and classification of hypercholesterolemia
Treatments Available at a Lipid Clinic
Lipid clinics have access to the full range of lipid-lowering therapies, including newer options that most primary care doctors have limited experience prescribing.
Inclisiran is a good example. It is an injectable medication given just twice a year by a healthcare professional, and it works by silencing the gene that produces a protein called PCSK9, which your liver uses to pull LDL receptors off its surface. Real-world data from a large U.S. lipid clinic showed that inclisiran reduced LDL cholesterol by about 45% in patients who were not switching from another PCSK9-targeting drug, and the rate of side effects was low, with only about 5% of patients reporting mild reactions that resolved after the second injection.17PubMed. Insights from a real-world experience with inclisiran at a large United States lipid clinic The twice-yearly dosing schedule solves a real problem: daily pills are easy to forget, and adherence to cholesterol medications drops steeply over time.
For patients with very severe FH or dangerously high Lp(a) who cannot reach safe levels with any combination of drugs, lipoprotein apheresis is an option that a lipid clinic can arrange. Apheresis works like dialysis for cholesterol: blood is drawn, run through a machine that strips out the harmful lipoproteins, and returned. Beyond just lowering lipid levels, the procedure reduces inflammation-promoting and clot-promoting factors in the blood. Observational studies in patients with elevated Lp(a) have shown cardiovascular events reduced by more than 80% with apheresis.18PubMed Central. Lipoprotein apheresis in the management of severe hypercholesterolemia and of elevation of lipoprotein(a): current perspectives and patient selection Despite its effectiveness, apheresis is significantly underused in the United States relative to its approved indications.19PubMed. Lipoprotein Apheresis: Utility, Outcomes, and Implementation in Clinical Practice: A Scientific Statement From the American Heart Association
Managing Statin Side Effects
A substantial portion of lipid clinic referrals involve patients who have stopped their statins because of side effects, most commonly muscle aches. The reality of statin intolerance is complicated. True pharmacological intolerance exists, but studies consistently show that a “nocebo” effect, where expecting side effects produces perceived symptoms, plays a significant role. The National Lipid Association’s consensus statement recommends that clinicians identify modifiable risk factors for intolerance and then systematically try different statins, doses, and dosing frequencies to find a tolerable regimen. For patients who still cannot tolerate any statin, non-statin therapies with proven cardiovascular outcomes data are favored, and in high-risk patients, those therapies should start promptly to limit the time spent exposed to elevated cholesterol levels.2Journal of Clinical Lipidology. Update on statin intolerance: A final consensus statement from the National Lipid Association Expert Panel on Statin Intolerance
This systematic approach is something a lipid clinic does routinely and a general practitioner may not have time to manage through multiple trial-and-error appointments.
Do Lipid Clinics Actually Get Better Results?
The evidence says yes. A study comparing a secondary prevention lipid clinic to usual cardiology care found that after three years, lipid clinic patients reached their LDL cholesterol goals significantly more often: about 82% hit the standard target compared with 73% under routine cardiology care, and 42% hit the more aggressive optional target compared with 29%.20PubMed. A secondary prevention lipid clinic reaches low-density lipoprotein cholesterol goals more often than usual cardiology care with coronary heart disease The lipid clinic patients also ended up with lower total cholesterol, lower triglycerides, and higher HDL on average.
Even lipid clinics run by clinical pharmacists rather than physicians have shown strong results. One pharmacist-managed clinic achieved LDL goals in 69% of patients at six months, compared with 50% of controls, and compliance with both lab work and medication refills improved dramatically.21PubMed. Effect of a clinical pharmacist-managed lipid clinic on achieving National Cholesterol Education Program low-density lipoprotein goals That last point, adherence, is arguably the most important number. The best medication in the world does nothing if it stays in the bottle. Lipid clinics tend to create structures, regular follow-ups, lab monitoring, coordinated refills, that keep patients on track.
One specialist clinic reported an overall LDL reduction of 36% across its patients, which translates to a projected reduction of more than one-third in future cardiovascular events, and that estimate did not even account for additional improvements in blood pressure and smoking cessation that the clinic also achieved.1PubMed. The value of a specialist lipid clinic
Lipid Screening and Clinics for Children
Lipid clinics are not just for adults. Universal cholesterol screening in childhood is recommended specifically to catch inherited disorders like FH early enough for treatment to prevent the decades of arterial damage that would otherwise start in childhood.22PubMed Central. Screening and Management of Dyslipidemia in Children and Adolescents Children identified with FH through screening or family cascade testing are typically managed by pediatric lipid specialists. Treatment in children usually starts with dietary changes and may include statins starting around age eight to ten if LDL levels remain very high. Lipoprotein apheresis is also used in children with the severe homozygous form of FH, where LDL levels can exceed 500 mg/dL without treatment.19PubMed. Lipoprotein Apheresis: Utility, Outcomes, and Implementation in Clinical Practice: A Scientific Statement From the American Heart Association
If your child has been flagged with high cholesterol on a routine screen, or if FH runs in your family, a pediatric lipid clinic is the right next step. The earlier treatment starts in these genetic conditions, the more years of protection you buy.
How Remote Monitoring Is Expanding Access
One barrier to lipid clinic care has always been geography: these clinics tend to be in academic medical centers in large cities. Telehealth has started to chip away at that problem. A recent study evaluated whether nonfasting blood work processed with machine learning could accurately estimate LDL cholesterol without requiring an in-person visit for a blood pressure reading. The results showed that a labs-only model, without blood pressure data, performed just as well, with misclassification rates at key treatment thresholds of roughly 3% to 4%.23PubMed Central. Nonfasting, Telehealth-Ready LDL-C Testing With Machine Learning to Improve Cardiovascular Access and Equity
What this means in practice is that you could get a nonfasting blood draw at a retail pharmacy, a workplace health screening, or even through a home phlebotomy service, and have the results fed into a telehealth consultation with a lipid specialist without ever setting foot in a hospital. The accuracy held up in both fasting and nonfasting conditions, which removes another logistical headache. This kind of workflow is still emerging, but it points toward a future where living far from an academic center no longer means going without specialist lipid care.